Efficacity of tDCS in catatonic patients with Phelan McDermid syndrome, a case series

Efficacity of tDCS in catatonic patients with Phelan McDermid syndrome, a case series

Bibliographic Details
Main Authors:	Mylène Moyal, Marion Plaze, Ambre Baruchet, David Attali, Cora Cravero, Marie Raffin, Angèle Consoli, David Cohen, Alexandre Haroche, Boris Chaumette
Format:	Article
Language:	English
Published:	Elsevier 2022-11-01
Series:	Brain Stimulation
Subjects:	Catatonia Phelan-McDermid syndrome SHANK3 tDCS Neurostimulation Transcranial direct current stimulation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1935861X22002285

Similar Items

Dissecting the Heterogeneity of Autism: Focus on Phelan-McDermid Syndrome
by: C. Lamschtein, et al.
Published: (2022-06-01)

Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
by: Teresa M. Kohlenberg, et al.
Published: (2020-02-01)

Clinical and Genetic Aspects of Phelan–McDermid Syndrome: An Interdisciplinary Approach to Management
by: Francisco Cammarata-Scalisi, et al.
Published: (2022-03-01)

Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature
by: Alexander Kolevzon, et al.
Published: (2019-12-01)

Phelan-McDermid syndrome: a classification system after 30 years of experience
by: Katy Phelan, et al.
Published: (2022-01-01)

Characterisation of the clinical phenotype in Phelan-McDermid syndrome
by: Mónica Burdeus-Olavarrieta, et al.
Published: (2021-07-01)

A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
by: J. Fastman, et al.
Published: (2021-09-01)

Descriptive Analysis of Adaptive Behavior in Phelan–McDermid Syndrome and Autism Spectrum Disorder
by: Sergio Serrada-Tejeda, et al.
Published: (2022-07-01)

Caregiver perspectives on patient-focused drug development for Phelan-McDermid syndrome
by: Luciana Gizzo, et al.
Published: (2024-03-01)

Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
by: Sarah Jesse, et al.
Published: (2023-03-01)

Prospective One-Year Follow-Up of Sensory Processing in Phelan–McDermid Syndrome
by: Sergio Serrada-Tejeda, et al.
Published: (2023-06-01)

Phelan–McDermid Syndrome in Pediatric Patients With Novel Mutations: Genetic and Phenotypic Analyses
by: Liang Chen, et al.
Published: (2022-08-01)

A proof-of-concept study of growth hormone in children with Phelan–McDermid syndrome
by: S. Sethuram, et al.
Published: (2022-01-01)

Neurodegeneration or dysfunction in Phelan-McDermid syndrome? A multimodal approach with CSF and computational MRI
by: Sarah Jesse, et al.
Published: (2023-09-01)

Sleep and Phelan–McDermid Syndrome: Lessons from the International Registry and the scientific literature
by: Bridgette A. Moffitt, et al.
Published: (2022-10-01)

Fraternal twins with Phelan-McDermid syndrome not involving the SHANK3 gene: case report and literature review
by: Shan Li, et al.
Published: (2020-10-01)

Homer1a regulates Shank3 expression and underlies behavioral vulnerability to stress in a model of Phelan-McDermid syndrome
by: Raozhou Lin, et al.
Published: (2021-11-01)

Sensory Reactivity Phenotype in Phelan–McDermid Syndrome Is Distinct from Idiopathic ASD
by: Teresa Tavassoli, et al.
Published: (2021-06-01)

Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome
by: Brianna Dyar, et al.
Published: (2021-07-01)

Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression—A Case Report
by: Sarah Jesse, et al.
Published: (2021-02-01)

Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome
by: A. Kolevzon, et al.
Published: (2022-04-01)

Síndrome de Phelan-McDermid: reporte de un caso y revisión de la literatura
by: Mariana Hernández Gómez, et al.
Published: (2018-01-01)

A 29 Mainland Chinese cohort of patients with Phelan–McDermid syndrome: genotype–phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes
by: Na Xu, et al.
Published: (2020-11-01)

Neurocognitive follow‐up in adult siblings with Phelan–McDermid syndrome due to a novel SHANK3 splicing site mutation
by: Minna Kankuri‐Tammilehto, et al.
Published: (2021-12-01)

Bringing everyone to the table – findings from the 2018 Phelan-McDermid Syndrome Foundation International Conference
by: Kimberly Goodspeed, et al.
Published: (2020-06-01)

Drugs prescribed for Phelan-McDermid syndrome differentially impact sensory behaviors in shank3 zebrafish models. [version 2; peer review: 2 approved]
by: Robert A. Kozol, et al.
Published: (2023-09-01)

Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals
by: Julián Nevado, et al.
Published: (2022-04-01)

Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations
by: Silvia De Rubeis, et al.
Published: (2018-04-01)

Prospective study of autism phenomenology and the behavioural phenotype of Phelan–McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder
by: Caroline Richards, et al.
Published: (2017-11-01)

Understanding Behavior in Phelan-McDermid Syndrome
by: Annemiek M. Landlust, et al.
Published: (2022-05-01)

Phenotypic Variability in Phelan–McDermid Syndrome and Its Putative Link to Environmental Factors
by: Luigi Boccuto, et al.
Published: (2022-03-01)

A case report of Phelan-McDermid syndrome: preliminary results of the treatment with growth hormone therapy
by: Rui Jin Xie, et al.
Published: (2021-03-01)

Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
by: Bridgette A. Moffitt, et al.
Published: (2023-02-01)

The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermid Syndrome and NRXN1 Deletions
by: Jennifer Cooke, et al.
Published: (2022-02-01)

Prenatal and postnatal diagnosis of Phelan–McDermid syndrome: A report of 21 cases from a medical center and review of the literature
by: Ying Hao, et al.
Published: (2022-08-01)

The role of genetic research in autism treatment Phelan-McDermid syndrome: Sasha’s story
by: Solovyeva N.V., et al.
Published: (2016-06-01)

Targeted next-generation sequencing identifies the disruption of the SHANK3 and RYR2 genes in a patient carrying a de novo t(1;22)(q43;q13.3) associated with signs of Phelan-McDermid syndrome
by: Maria Clara Bonaglia, et al.
Published: (2020-06-01)

Neural Markers of Auditory Response and Habituation in Phelan-McDermid Syndrome
by: Emily L. Isenstein, et al.
Published: (2022-05-01)

Sensory Processing Phenotypes in Phelan-McDermid Syndrome and <i>SYNGAP1</i>-Related Intellectual Disability
by: Ariel M. Lyons-Warren, et al.
Published: (2022-01-01)

State of the Science for Kidney Disorders in Phelan-McDermid Syndrome: UPK3A, FBLN1, WNT7B, and CELSR1 as Candidate Genes
by: Megan D. McCoy, et al.
Published: (2022-06-01)